|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 76.41 CAD | +0.50% |
|
+4.87% | +12.88% |
| 05-09 | Great-West Lifeco Inc. announces Quarterly dividend, payable on June 30, 2026 | CI |
| 05-08 | Canada research roundup-Aritzia, Knight Therapeutics, WSP Global | RE |
Company Valuation: Great-West Lifeco Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 35,322 | 29,166 | 40,882 | 44,419 | 61,406 | 68,619 | - | - |
| Change | - | -17.43% | 40.17% | 8.65% | 38.24% | 11.75% | - | - |
| Enterprise Value (EV) | 35,322 | 29,166 | 40,882 | 44,419 | 61,406 | 68,619 | 68,619 | 68,619 |
| Change | - | -17.43% | 40.17% | 8.65% | 38.24% | 11.75% | 0% | 0% |
| P/E ratio | 11.3x | 9.07x | 14.9x | 11.3x | 15.9x | 14.3x | 13.3x | 15.4x |
| PBR | 1.54x | 1.18x | 1.81x | 1.75x | 2.41x | 2.53x | 2.34x | 2.26x |
| PEG | - | 3.31x | -1x | 0.3x | 13.39x | 0.6x | 1.63x | -1.1x |
| Capitalization / Revenue | 0.55x | 0.65x | 0.98x | 1.12x | 1.4x | 1.68x | 1.61x | 1.55x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 1.68x | 1.61x | 1.55x |
| EV / EBITDA | - | - | - | - | - | - | - | - |
| EV / EBIT | 0x | 0x | 0x | - | - | 13.5x | 12.3x | - |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | 1.804 | 1.96 | 2.08 | 2.22 | 2.44 | 2.686 | 2.936 | 3.161 |
| Rate of return | 4.75% | 6.26% | 4.74% | 4.66% | 3.6% | 3.52% | 3.84% | 4.14% |
| EPS 2 | 3.36 | 3.452 | 2.94 | 4.21 | 4.26 | 5.33 | 5.764 | 4.97 |
| Distribution rate | 53.7% | 56.8% | 70.7% | 52.7% | 57.3% | 50.4% | 50.9% | 63.6% |
| Net sales 1 | 64,417 | 44,662 | 41,629 | 39,797 | 43,976 | 40,903 | 42,666 | 44,275 |
| EBITDA | - | - | - | - | - | - | - | - |
| EBIT 1 | 4,323 | 4,082 | 4,299 | - | - | 5,072 | 5,593 | - |
| Net income 1 | 3,128 | 3,219 | 2,738 | 3,940 | 3,960 | 4,775 | 5,121 | 5,315 |
| Net Debt | - | - | - | - | - | - | - | - |
| Reference price 2 | 37.96 | 31.30 | 43.86 | 47.67 | 67.69 | 76.41 | 76.41 | 76.41 |
| Nbr of stocks (in thousands) | 930,495 | 931,818 | 932,107 | 931,800 | 907,159 | 898,039 | - | - |
| Announcement Date | 2/9/22 | 2/8/23 | 2/14/24 | 2/5/25 | 2/11/26 | - | - | - |
1CAD in Million2CAD
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 14.34x | - | - | 3.52% | 50.09B | ||
| 7.24x | 5.13x | - | 4.97% | 152B | ||
| 9.42x | 0.89x | - | 6.38% | 93.62B | ||
| 12.55x | 0.97x | - | 4.65% | 68.11B | ||
| 12.66x | - | - | 3.51% | 66.55B | ||
| 15.96x | 3.08x | - | 2.12% | 58.78B | ||
| 9.2x | - | - | 3% | 50.24B | ||
| 6.49x | 0.87x | - | 3.45% | 48.23B | ||
| 14.99x | - | - | 3.92% | 39.24B | ||
| 13.19x | - | - | 1.95% | 39.01B | ||
| Average | 11.60x | 2.19x | 3.75% | 66.59B | ||
| Weighted average by Cap. | 10.83x | 2.74x | 4.13% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- GWO Stock
- Valuation Great-West Lifeco Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















